<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
    <id>https://macwaneric.github.io/cancer.rss.feed/index.html</id>
    <title>osmos::feed</title>
    <updated>2022-06-07T06:25:53.492Z</updated>
    <generator>osmosfeed 1.14.4</generator>
    <link rel="alternate" href="https://macwaneric.github.io/cancer.rss.feed/index.html"/>
    <link rel="self" href="https://macwaneric.github.io/cancer.rss.feed/feed.atom"/>
    <entry>
        <title type="html"><![CDATA[@NatureRevCancer: NEW content online! Nodal interferon exposure drives tumour-specific tolerance]]></title>
        <id>72a3a11d39c217b1a80cbb551444e6f6</id>
        <link href="https://twitter.com/NatureRevCancer/status/1533878403463405569"/>
        <updated>2022-06-06T18:28:04.000Z</updated>
        <summary type="html"><![CDATA[NEW content online! Nodal interferon exposure drives tumour-specific tolerance https://t.co/FT4NeBcFTg pic.twitter.com/NRHkVDUsOr
— NatureReviewsCancer (@NatureRevCancer) June 6, 2022]]></summary>
        <author>
            <name>@NatureRevCancer</name>
        </author>
    </entry>
    <entry>
        <title type="html"><![CDATA[Nodal interferon exposure drives tumour-specific tolerance]]></title>
        <id>f7b727d0b37e029d75b7b872a8c65499</id>
        <link href="https://www.nature.com/articles/s41568-022-00489-8"/>
        <updated>2022-06-06T00:00:00.000Z</updated>
        <summary type="html"><![CDATA[Nature Reviews Cancer - Reticker-Flynn et al. show that exposure of melanoma cells to interferons and immune cells within lymph nodes leads to immune tolerance that promotes metastasis of both...]]></summary>
        <author>
            <name>Nature</name>
        </author>
    </entry>
    <entry>
        <title type="html"><![CDATA[@VIBConferences: #Cancer #immunotherapy has become a crucial pillar of anticancer therapy. 19 leading researchers at #ImmunoOnco22 will give new insights into the immune response to tumors and tackle unresolved questions.⏰Registration Deadline: Thursday 2 June. Read more]]></title>
        <id>bb6bc242bcbc356c4a38db850e74d812</id>
        <link href="https://twitter.com/VIBConferences/status/1531132720952266752"/>
        <updated>2022-05-30T04:37:42.000Z</updated>
        <summary type="html"><![CDATA[#Cancer #immunotherapy has become a crucial pillar of anticancer therapy. 19 leading researchers at #ImmunoOnco22 will give new insights into the immune response to tumors and tackle unresolved questions.
⏰Registration Deadline: Thursday 2 June. Read more https://t.co/cc0HC5cj6W pic.twitter.com/u8LFuzBbsV
— VIB Conferences (@VIBConferences) May 30, 2022]]></summary>
        <author>
            <name>@VIBConferences</name>
        </author>
    </entry>
    <entry>
        <title type="html"><![CDATA[@NatureRevCancer: NEW content online! Nonsense-mediated RNA decay: an emerging modulator of malignancy]]></title>
        <id>ed6c996dc1a718afb523de6229a53131</id>
        <link href="https://twitter.com/NatureRevCancer/status/1530198403686072320"/>
        <updated>2022-05-27T14:45:03.000Z</updated>
        <summary type="html"><![CDATA[NEW content online! Nonsense-mediated RNA decay: an emerging modulator of malignancy https://t.co/wjuHplkpof pic.twitter.com/1SoKYhRsPO
— NatureReviewsCancer (@NatureRevCancer) May 27, 2022]]></summary>
        <author>
            <name>@NatureRevCancer</name>
        </author>
    </entry>
    <entry>
        <title type="html"><![CDATA[@NatureRevCancer: Our June issue, out NOW! With articles on #therapyresistance, #senescence & targeting CDK4 & CDK6 in #cancer! Plus, a Comment on cancer mRNA vaccines as well as the launch of our new Tools of the Trade articles #NRCToT. So much content 👇🏻💌]]></title>
        <id>d15a3a4b24853812d7fa21fd56de5815</id>
        <link href="https://twitter.com/NatureRevCancer/status/1530174481313972224"/>
        <updated>2022-05-27T13:10:00.000Z</updated>
        <summary type="html"><![CDATA[Our June issue, out NOW! With articles on #therapyresistance, #senescence & targeting CDK4 & CDK6 in #cancer! Plus, a Comment on cancer mRNA vaccines as well as the launch of our new Tools of the Trade articles #NRCToT. So much content 👇🏻
💌 https://t.co/Fo6XRWV3OZ@natrescancer pic.twitter.com/rbxRPqLV6g
— NatureReviewsCancer (@NatureRevCancer) May 27, 2022]]></summary>
        <author>
            <name>@NatureRevCancer</name>
        </author>
    </entry>
    <entry>
        <title type="html"><![CDATA[Nonsense-mediated RNA decay: an emerging modulator of malignancy]]></title>
        <id>8d6d36d2922578f6dbce923c700d8678</id>
        <link href="https://www.nature.com/articles/s41568-022-00481-2"/>
        <updated>2022-05-27T00:00:00.000Z</updated>
        <summary type="html"><![CDATA[Nature Reviews Cancer - Nonsense-mediated RNA decay (NMD) is a highly conserved RNA surveillance pathway that selectively degrades both normal and mutant mRNAs harbouring stop codons in specific...]]></summary>
        <author>
            <name>Nature</name>
        </author>
    </entry>
    <entry>
        <title type="html"><![CDATA[@UlrikeHarjes: This Review by @MarcusDGon @cantleylab is part of the @NatureRevCancer series on #Diet & #SystemicMetabolism in cancer:  do love this topic in general plus I am handling research at @NatureMedicine now.. get in touch if you have something of interest☺️]]></title>
        <id>fe13755a2693ea65459e5e21df097d2a</id>
        <link href="https://twitter.com/UlrikeHarjes/status/1529747629936193537"/>
        <updated>2022-05-26T08:53:50.000Z</updated>
        <summary type="html"><![CDATA[This Review by @MarcusDGon @cantleylab is part of the @NatureRevCancer series on #Diet & #SystemicMetabolism in cancer: https://t.co/p3Y2cdNhco
I do love this topic in general plus I am handling research at @NatureMedicine now.. get in touch if you have something of interest☺️ https://t.co/qWH2dTv8j9
— Ulrike Harjes (@UlrikeHarjes) May 26, 2022]]></summary>
        <author>
            <name>@UlrikeHarjes</name>
        </author>
    </entry>
    <entry>
        <title type="html"><![CDATA[@NatureRevCancer: NEW content online! Developing dietary interventions as therapy for cancer]]></title>
        <id>9ba5279424b31b0122a4ae20c18e6d03</id>
        <link href="https://twitter.com/NatureRevCancer/status/1529516411059437568"/>
        <updated>2022-05-25T17:35:04.000Z</updated>
        <summary type="html"><![CDATA[NEW content online! Developing dietary interventions as therapy for cancer https://t.co/ijuqctk1wJ pic.twitter.com/KHPpMKnCFa
— NatureReviewsCancer (@NatureRevCancer) May 25, 2022]]></summary>
        <author>
            <name>@NatureRevCancer</name>
        </author>
    </entry>
    <entry>
        <title type="html"><![CDATA[Developing dietary interventions as therapy for cancer]]></title>
        <id>c101257deaef49ddfc3d6ae6922f3232</id>
        <link href="https://www.nature.com/articles/s41568-022-00485-y"/>
        <updated>2022-05-25T00:00:00.000Z</updated>
        <summary type="html"><![CDATA[Nature Reviews Cancer - This Review discusses the metabolic alterations and vulnerabilities across multiple types of cancer, and describes how these could potentially be targeted using diet in...]]></summary>
        <author>
            <name>Nature</name>
        </author>
    </entry>
    <entry>
        <title type="html"><![CDATA[@cic_film: #ColoniesInConflict - First film in India about Apis dorsata a honeybee species we see around our neighbourhood but know so little about. In the film we tried to follow the trajectory of the Rockbees and witness a possible decline in their population.]]></title>
        <id>f4f67815c591ec77196ed7a0053fd366</id>
        <link href="https://twitter.com/cic_film/status/1526959426661326849"/>
        <updated>2022-05-18T16:14:31.000Z</updated>
        <summary type="html"><![CDATA[#ColoniesInConflict - First film in India about Apis dorsata a honeybee species we see around our neighbourhood but know so little about. In the film we tried to follow the trajectory of the Rockbees and witness a possible decline in their population. pic.twitter.com/hm9El1gtRe
— coloniesinconflict_film (@cic_film) May 18, 2022]]></summary>
        <author>
            <name>@cic_film</name>
        </author>
    </entry>
    <entry>
        <title type="html"><![CDATA[@NatureRevCancer: NEW content online! Digging for treasures in the tumour interactome]]></title>
        <id>611d40f2e6ea2796b028bebda41a86dd</id>
        <link href="https://twitter.com/NatureRevCancer/status/1526928478490095616"/>
        <updated>2022-05-18T14:11:32.000Z</updated>
        <summary type="html"><![CDATA[NEW content online! Digging for treasures in the tumour interactome https://t.co/NhHYAwUgLE
— NatureReviewsCancer (@NatureRevCancer) May 18, 2022]]></summary>
        <author>
            <name>@NatureRevCancer</name>
        </author>
    </entry>
    <entry>
        <title type="html"><![CDATA[Digging for treasures in the tumour interactome]]></title>
        <id>7a839bbf574698d860220c4191201c86</id>
        <link href="https://www.nature.com/articles/s41568-022-00487-w"/>
        <updated>2022-05-18T00:00:00.000Z</updated>
        <summary type="html"><![CDATA[Nature Reviews Cancer - In this Tools of the Trade article, Amir Giladi describes the development and use of PIC-seq, which enables the direct enrichment and analysis of conjugates of physically...]]></summary>
        <author>
            <name>Nature</name>
        </author>
    </entry>
    <entry>
        <title type="html"><![CDATA[@NatureRevCancer: As part of our overall commitment to diversity, equity and inclusion at Springer Nature, we’d like to better understand what DEI means within the global research community. Take the survey here]]></title>
        <id>9590a971b00448cd312078183965b21d</id>
        <link href="https://twitter.com/NatureRevCancer/status/1526560254091313156"/>
        <updated>2022-05-17T13:48:21.000Z</updated>
        <summary type="html"><![CDATA[As part of our overall commitment to diversity, equity and inclusion at Springer Nature, we’d like to better understand what DEI means within the global research community. Take the survey here https://t.co/03yLiUxFTq
— NatureReviewsCancer (@NatureRevCancer) May 17, 2022]]></summary>
        <author>
            <name>@NatureRevCancer</name>
        </author>
    </entry>
    <entry>
        <title type="html"><![CDATA[@NatureRevCancer: Newsflash! We have a new article type in the journal - Tools of the Trade #NRCToT 🧰 🛠️ where we hope to enable more #ECRs to interact with the editorial team & have a bigger voice in our content. For more info, check out the Editorial 👇🏻]]></title>
        <id>aa38ff4245b93e964773f191844ddc7a</id>
        <link href="https://twitter.com/NatureRevCancer/status/1524772831904509953"/>
        <updated>2022-05-12T15:25:46.000Z</updated>
        <summary type="html"><![CDATA[Newsflash! We have a new article type in the journal - Tools of the Trade #NRCToT 🧰 🛠️ where we hope to enable more #ECRs to interact with the editorial team & have a bigger voice in our content. For more info, check out the Editorial 👇🏻 https://t.co/VbyoUJmTRJ
— NatureReviewsCancer (@NatureRevCancer) May 12, 2022]]></summary>
        <author>
            <name>@NatureRevCancer</name>
        </author>
    </entry>
    <entry>
        <title type="html"><![CDATA[@Deepikaabais: It has been a long journey, but you're finally here! Presenting Dr. Arumoy Chatterjee! 🍺 @Arumoy89]]></title>
        <id>b3dbcd8c36cec127161aeecd6ad419cb</id>
        <link href="https://twitter.com/Deepikaabais/status/1524712898203103232"/>
        <updated>2022-05-12T11:27:37.000Z</updated>
        <summary type="html"><![CDATA[It has been a long journey, but you're finally here! Presenting Dr. Arumoy Chatterjee! 🍺 @Arumoy89 pic.twitter.com/fTKoNZ6vZP
— Deepika Bais (@Deepikaabais) May 12, 2022]]></summary>
        <author>
            <name>@Deepikaabais</name>
        </author>
    </entry>
    <entry>
        <title type="html"><![CDATA[@NatureRevCancer: NEW content online! Tools for the next generation]]></title>
        <id>65aca76b9f794aaa668d84ad32dca4a0</id>
        <link href="https://twitter.com/NatureRevCancer/status/1524068259712036864"/>
        <updated>2022-05-10T16:46:03.000Z</updated>
        <summary type="html"><![CDATA[NEW content online! Tools for the next generation https://t.co/lEzTPFYDf5
— NatureReviewsCancer (@NatureRevCancer) May 10, 2022]]></summary>
        <author>
            <name>@NatureRevCancer</name>
        </author>
    </entry>
    <entry>
        <title type="html"><![CDATA[@NatureRevCancer: NEW content online! Hunting down rare drug-tolerant cycling cells with Watermelon]]></title>
        <id>afa9b6784b4ccc7c05ed4efd26ddfb2d</id>
        <link href="https://twitter.com/NatureRevCancer/status/1524022709386190856"/>
        <updated>2022-05-10T13:45:03.000Z</updated>
        <summary type="html"><![CDATA[NEW content online! Hunting down rare drug-tolerant cycling cells with Watermelon https://t.co/XXT0c9SAYX
— NatureReviewsCancer (@NatureRevCancer) May 10, 2022]]></summary>
        <author>
            <name>@NatureRevCancer</name>
        </author>
    </entry>
    <entry>
        <title type="html"><![CDATA[@eagermeagre: Bangalore folks, come join us for the premiere of the film Colonies in Conflict by @rajanimani on 22nd May, Sunday at @bicblr!@cic_film is about the human bee conflict and how we can coexist with them in an urban landscape.]]></title>
        <id>7bd32c707fb3ff520d7c3777fccbf1bc</id>
        <link href="https://twitter.com/eagermeagre/status/1523936974750760960"/>
        <updated>2022-05-10T08:04:22.000Z</updated>
        <summary type="html"><![CDATA[Bangalore folks, come join us for the premiere of the film Colonies in Conflict by @rajanimani on 22nd May, Sunday at @bicblr!@cic_film is about the human bee conflict and how we can coexist with them in an urban landscape. pic.twitter.com/acufJ8QsZa
— Manal Shakeel (@eagermeagre) May 10, 2022]]></summary>
        <author>
            <name>@eagermeagre</name>
        </author>
    </entry>
    <entry>
        <title type="html"><![CDATA[Tools for the next generation]]></title>
        <id>9182f1ae9abca7f95fd9b8e04c30b182</id>
        <link href="https://www.nature.com/articles/s41568-022-00484-z"/>
        <updated>2022-05-10T00:00:00.000Z</updated>
        <summary type="html"><![CDATA[Nature Reviews Cancer - This month, Nature Reviews Cancer launches Tools of the Trade articles, in which early career researchers can discuss the methods or techniques that they use to conduct...]]></summary>
        <author>
            <name>Nature</name>
        </author>
    </entry>
    <entry>
        <title type="html"><![CDATA[Hunting down rare drug-tolerant cycling cells with Watermelon]]></title>
        <id>b875e79b55953771afb10c854b7648be</id>
        <link href="https://www.nature.com/articles/s41568-022-00483-0"/>
        <updated>2022-05-10T00:00:00.000Z</updated>
        <summary type="html"><![CDATA[Nature Reviews Cancer - In this Tools of the Trade article, Yaara Oren describes the development and use of the Watermelon system to simultaneously track the lineage, transcriptional profile and...]]></summary>
        <author>
            <name>Nature</name>
        </author>
    </entry>
</feed>